APHA
Hindenburg Hit Piece – FYI Aphria Upside not Driven by Latin America
Bottom Line: We aren't in a place to debate the allegations of whether an office exists or if a listed…
Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (November 17, 2018)
Global Markets Could be in for a Rebound Bottom Line: Grizzle economist Chris Wood thinks there is a good chance markets…
Canopy Growth Q1 2019 Earnings – The Night is Always Darkest Before the Dawn
Bottom Line: Luckily for Canopy, this was largely a meaningless quarter, because if they put up results like this in…
Tilray Q3 2018 Earnings – Is the Hype Justified?
Bottom Line This was the second quarter we got to see what Tilray is all about and we couldn't find…
Aurora Cannabis Q1 2019 Earnings – A Taste of Things to Come
Bottom Line Though earnings did not include results from early recreational sales, Aurora gave us some clues about how they…
Aphria Bolsters German Operations with CC Pharma Acquisition
Aphria has snapped up German cannabis distributor CC Pharma in a €24.5 million ($27.8 million) deal that is expected to…
Aphria Inc. Promotes Jakob Ripshtein From CCO To Company President
Aphria Inc. (TSX: APHA, NYSE: APHA) officially announced Jakob Ripshtein as the new president of Aphria, taking responsibility for worldwide…
Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (November 3, 2018)
Grizzle Does a Deep Dive into Aphria Bottom Line: Grizzle thinks Aphria is worth $40/sh today based the current asset…
Aphria Confirms Trading Of Common Shares Will Commence On NYSE Nov. 2
While cannabis remains illegal on the federal level in the United States, and is even listed as a Schedule I…